Big Gain For Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc. (CTXR:NASDAQ) rocketted at $3.23, representing a gain of 17.5%. On Mon, Jun 14, 2021, CTXR:NASDAQ hit a New 2-Week High of $2.75. The stock got featured on our News Catalysts scanner on Tue, Jun 15, 2021 at 10:21 AM in the 'MISCELLANEOUS' category. From Tue, Jun 01, 2021, the stock recorded 66.67% Up Days and 60.00% Green Days
The stock spiked on Mon, Feb 22, 2021 at $2.9 with a volume of 146M+, and its share price has been moving sideways in recent weeks.
About Citius Pharmaceuticals, Inc. (CTXR:NASDAQ)
Citius Pharmaceuticals Inc is a specialty pharmaceutical company engaged in development and commercialization of therapeutic products for markets using patented or proprietary formulations and modified drug delivery technology.
Top 10 Gainers:
- ALF (ALF:NASDAQ), 104.4%
- Torchlight Energy Resources, Inc. (TRCH:NASDAQ), 41.62%
- Clearside Biomedical, Inc. (CLSD:NASDAQ), 37.75%
- Unique Fabricating, Inc. (UFAB:NYSEMKT), 37.31%
- HMG/Courtland Properties, Inc. (HMG:NYSEMKT), 25.21%
- FOA (FOA:NYSE), 21.78%
- TDH Holdings, Inc. (PETZ:NASDAQ), 18.96%
- FUSN (FUSN:NASDAQ), 18.14%
- Citius Pharmaceuticals, Inc. (CTXR:NASDAQ), 17.45%
- GOEV (GOEV:NASDAQ), 16.81%